Transgene completes €152 million rights issue
This article was originally published in Scrip
Transgene has completed its previously announced rights issue, raising €152 million in gross proceeds as expected, through the sale of just under 9.5 million newly issued shares. Institut Mérieux, the company's majority shareholder, retains a 55.2% stake. Settlement, delivery and the start of trading of the new shares are planned for 7 June.